Forget BigBear.ai: This Mission‑Critical AI Platform With Exploding Commercial Revenue Is the Better Long‑Term Bet

Palantir reported a strong Q3 2025 with total revenue up 63% to $1.18 billion, commercial revenue +73% YoY to $548 million (46% of sales), commercial customer count +49% YoY to 742, 204 deals ≥ $1M and earnings up 110%—driving a premium ~111x sales multiple. By contrast BigBear.ai missed Q2, cut full-year guidance (2025 revenue guided to $125M–$140M vs $158M in 2024) and remains heavily reliant on government contracts, trading at a discounted 12.6x sales. The piece argues Palantir’s commercial traction and expanding contract sizes position it to capture a larger share of a growing AI platform market (Precedence Research: $26B → $88B by 2034), while BigBear.ai’s outlook and customer mix make it a riskier investment despite a lower valuation.

Analysis

Market structure: Palantir (PLTR) is capturing commercial AI spend with accelerating customer additions (742 customers, +49% y/y) and large deal flow (204 deals ≥$1M, ~2x y/y; >3x for $10M+ deals), implying revenue growth compounding well above the 14% AI-platform TAM CAGR — expect market share gains and pricing power for PLTR over 12–36 months. BigBear.ai (BBAI) is concentrated in federal contracts and guiding 2025 revenue $125–140M (down from $158M in 2024), signaling demand/TAM exposure mismatch and higher revenue volatility; its 12.6x sales multiple discounts structural decline risk versus PLTR’s 111x. Cross-asset: a rotation into PLTR/NVDA-style growth tends to steepen yields (risk-on), lift USD and vol compression in large-cap options while elevating idiosyncratic vol for small defense names (BBAI); expect bid for protection (puts) on BBAI and higher implied vols. Competitive dynamics: incumbency, integration moat, and expanding average contract value favor PLTR’s upsell-led margin expansion; BBAI faces pricing pressure and contract timing risk that can cede share to better-funded rivals or prime contractors over 12–24 months.

Risk assessment: Tail risks include US regulatory limits on AI exports or strict procurement shifts away from small vendors (low-probability, high-impact, 6–18 months), major contract losses for BBAI, or product failures for PLTR at enterprise scale. Immediate (days): tradeable reactions to earnings/guidance; short-term (weeks–months): contract awards and FY guidance revisions; long-term (quarters–years): market-share shifts and margin expansion for PLTR. Hidden dependencies: BBAI’s revenue concentrated in a few federal programs and timing lags; PLTR’s commercial momentum depends on sustained client integration cycles and macro capex. Catalysts: BBAI Q4 release and FY 2026 guidance (next 30–90 days), PLTR quarterly with commercial deal cadence (next 90 days), and FY federal budget appropriations cycle (6–12 months).

Trade implications: Primary directional: establish a tactical long in PLTR and a hedged bearish exposure to BBAI via options rather than naked shorting; prefer pair trade to isolate AI-platform secular vs federal-concentration risk. Options: buy calendar/LEAP calls on PLTR (12–24 month LEAP) or sell covered calls to monetize near-term IV; buy BBAI 3–6 month put spreads (cap cost) sized to 0.5–1.0% portfolio risk because borrow/short squeezes are possible. Sector rotation: shift 3–6% from small-cap defense/GovTech into large-cap AI infrastructure (PLTR, NVDA) and commercial SaaS; reduce pure-play federal-exposed small caps by similar amounts.

Contrarian angles: Consensus undervalues binary upside for BBAI if it wins a multi-year prime contract—a cheap way to hedge is buying small-size OTM calls (speculative, 6–12 month) while keeping core short protection. Conversely, PLTR’s 111x sales multiple prices near-perfect execution; downside is significant if commercial churn or slower deal conversion occurs — use protective collars if allocating >3% position. Historical parallels: government-concentrated tech names often see overshoots both ways around funding cycles (e.g., post-sequestration drawdowns then recoveries over 12–36 months), so size bets modestly and use time-limited options to control tail risk.

Key Decisions for Investors

• Establish a 2–3% long position in PLTR (equity or 12–24 month LEAP calls) within 2 weeks, target 30–50% upside over 12–24 months, place a 20% trailing stop or hedge with a 12–18 month put at ~30% OTM to limit downside.
• Enter a hedged bearish exposure to BBAI sized at 0.5–1.0% portfolio risk by buying 3–6 month put spreads (e.g., buy 25% OTM puts and sell 10% OTM puts) before its Q4 release; if implied vol rises >30% from today, trim premium and convert to shorter-dated protection.
• Implement a pair trade: long PLTR 2%, short BBAI synthetic via options (long PLTR LEAP calls funded by BBAI put spread premium) to express secular AI-platform vs government-concentration differential over 12–24 months.
• Reallocate 3–6% from small-cap government-dependent Tech/Defense names into large-cap AI exposure (PLTR, NVDA) over the next month, and reduce single-contract concentration positions where any one contract >15% of revenue.
• If BBAI trades down >25% on Q4 guidance miss, consider a small tactical long via 12-month OTM calls (size 0.25–0.5%) as a binary recovery play tied to a major contract award; exit within 9–12 months if no contract visibility.